Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine.
D000328:Adult; D000336:Aerosols; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D006383:Hemadsorption Inhibition Tests; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007115:Immunization Schedule; D005779:Immunodiffusion; D007074:Immunoglobulin G / Q000032:analysis; D007279:Injections, Subcutaneous; D008297:Male; D009297:Nasal Mucosa / Q000378:metabolism; D009500:Neutralization Tests; D009666:Nose / Q000276:immunology; D010047:Ovalbumin; D018108:Respirovirus / Q000276:immunology*; D012882:Skin Tests; D013183:Sputum / Q000276:immunology; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage*
D000336:Aerosols; D000906:Antibodies; D007074:Immunoglobulin G; D014765:Viral Vaccines; D010047:Ovalbumin